1 November 2023
CORS Conference Programme 2023
| Time | Event and Speaker / Details | |
|---|---|---|
| 9.30 - 10.00 | Registration and coffee | |
| 10.00-10.30 | Welcome, and a short overview of selected parts of the proposed pharma legislation Affiliate Professor, Nikolai C Brun, Copenhagen Centre for Regulatory Science, University of Copenhagen |
|
| 10.30-10.50 | The proposed pharma legislation - perspectives from patients Francois Houyez, Treatment Information and Access Director / Health Policy Advisor. European Organisation for Rare Diseases (Eurordis) |
|
| 11.50-11.20 | Coffee break | |
| 11.20-11.40 | The proposed pharma legislation - perspectives from the pharma industry Nick Sykes, Policy Advisor, Regulatory Strategy, EFPIA |
|
| 11.40-12.10 | The global 'side effects' of Europe's general pharma legislation and foreign actors' influence on the EC's proposal for review Katrina Perehudoff PhD, Assistant Professor, Faculty of Law, University of Amsterdam |
|
| 12.10-13.30 | Lunch + posters session | |
| 13.30-13.50 | The proposed pharma legislation - perspectives from the generic and biosimilar pharma industry Adrina van den Hoven, Director General of Medicines for Europe |
|
| 13.50-14.10 | The proposed pharma legislation - perspectives from the European Parliament Pernille Weiss, EPP Denmark, Rapporteur for the proposed directive relating to medicinal products for human use |
|
| 14.10-15.40 | Coffee break | |
| 14.40-15.00 | The proposed pharma legislation - perspectives from a regulator Lars Bo Nielsen, Director General, Danish Medicines Agency |
|
| 15.00-15.40 | Panel discussion Chair: Christine Hallgreen & Mathias Møllebæk, Copenhagen Centre for Regulatory Science, University of Copenhagen |
|
| 15.40-15.50 | Closing remarks | |